RegWardenFDA facility compliance records
Recall

Class II — ArjoHuntleigh Inc.

Recalling firmARJOHUNTLEIGH AB
Registered facilityARJOHUNTLEIGH AB (the firm's only registered facility)
ClassificationClass II
StatusTerminated
ReasonThe lock pin can become stuck in the "in" position during the manual rotation, resulting in the inability to prone a patient
ProductThe Rotoprone therapy System is an advanced patient care system for the treatment and prevention of pulmonary complications. The Rotoprone Therapy System provides up to 62 degrees in both prone and supine positions as well as Trendelenburg/Reverse Trendelenburg positioning. Product Usage: Use of the Rotoprone Therapy System is indicated for patients with severe acute respiratory distress syndrome (ARDS). These are critical patients who are at higher risk of cardiac arrest and mortality. Placing a patient in the prone position may reopen collapsed airways and thus improve pulmonary gas ex…
Quantity231 units
DistributionUS Nationwide and Middle East
Initiated2013-09-11
Classified2014-02-03
Terminated2015-01-08
Recall numberZ-0926-2014
InitiationVoluntary: Firm initiated

Source: U.S. FDA via openFDA (opens in a new tab) (device registration & enforcement). Data as of 2026-10-06. Verify this recall record at FDA → (opens in a new tab)

Cite this record

RegWarden. “Class II recall — ArjoHuntleigh Inc. (Z-0926-2014).” Compiled from U.S. FDA public records (openFDA; FDA Data Dashboard). Data as of 2026-10-06. https://regwarden.com/recall/67248/

Not open yet

Alerts for ARJOHUNTLEIGH AB

Watchlist alerts will email you when FDA publishes a new recall, inspection classification, or warning letter for a facility you follow. They aren't open to the public yet — leave your email and we'll tell you when they are.

Planned

Want a one-page facility brief?

A single-page summary of this facility's registration and recall history for diligence. Not selling it yet — register interest and we'll follow up.